Automated Patch Clamp System Market, By Technique (Automated Glass Pipette-based Patch Clamp, Micro-fabricated Planar Electrode-based Patch Clamp, and Automated TEVC On Xenopus Oocytes), By Amplifiers (8, 16, 384, 768, and Others), By End User (Contract R

Automated Patch Clamp System Market, By Technique (Automated Glass Pipette-based Patch Clamp, Micro-fabricated Planar Electrode-based Patch Clamp, and Automated TEVC On Xenopus Oocytes), By Amplifiers (8, 16, 384, 768, and Others), By End User (Contract Research Organization, Biopharmaceuticals, and Academic & Research Institutes), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

The techniques available for automated patch clamping are divided into three categories: the automated glass pipette-based patch clamp, the micro-fabricated planar electrode-based patch clamp, and automated TEVC on Xenopus oocytes. The use of automated patch clamp system has increased significantly to perform cardiac safety screening. For instance, automated patch clamp systems such as IonFlux Mercury HT manufactured by Fluxion Biosciences have been used for cardiac safety profiling (hERG).
Market players are focusing on launching advanced automated patch clamp systems, in order to strengthen their market presence and expand their product portfolio, which is expected to boost growth of the global automated patch clamp system market over the forecast period. For instance, in September 2020, Fluxion Biosciences launched IonFlux Mercury Ultra, a high-throughput automated patch clamp system.
Market Dynamics
Increasing research and development of therapeutic drugs and medical devices is expected to drive growth of the automated patch clamp system market over the forecast period. According to the United Nations Educational, Scientific and Cultural Organization (UNESCO), November 2016, an estimated US$ 1.7 trillion was spent on research and development for various medical applications, globally. Moreover, the U.S. Food and Drug Administration (FDA) and its Center for Drug Evaluation and Research (CDER) approved around 59 novel drugs in 2018 compared to 46 approvals of new molecule entities in 2017.
Moreover, according to the Pharma R&D Annual Review, 2021, an estimated number of drugs under pipeline in 2021 was around 16,181, while in 2018, it was around 15,267, resulting in an overall pipeline growth by 6% in 2018.
Key features of the study:
This report provides in-depth analysis of the global automated patch clamp system market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global automated patch clamp system market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Sophion Bioscience A/S, Nanion Technologies GmbH, NeoBiosystems, Inc., Multi Channel Systems MCS GmbH, Fluxion Biosciences, Molecular Devices, LLC, Scitech Korea Inc., and HEKA Elektronik GmbH
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global automated patch clamp system market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global automated patch clamp system market

Detailed Segmentation:
Global Automated Patch Clamp System Market, By Technique:
Automated Glass Pipette-based Patch Clamp
Micro-fabricated Planar Electrode-based Patch Clamp
Automated TEVC On Xenopus Oocytes
Global Automated Patch Clamp System Market, By Amplifiers:
8
16
384
768
Others
Global Automated Patch Clamp System Market, By End User:
Contract Research Organization
Biopharmaceuticals
Academic & Research Institutes
Global Automated Patch Clamp System Market, By Region:
North America
By Technique
Automated Glass Pipette-based Patch Clamp
Micro-fabricated Planar Electrode-based Patch Clamp
Automated TEVC On Xenopus Oocytes
By Amplifiers:
8
16
384
768
Others
By End User:
Contract Research Organization
Biopharmaceuticals
Academic & Research Institutes
By Country:
U.S.
Canada
Latin America
By Technique
Automated Glass Pipette-based Patch Clamp
Micro-fabricated Planar Electrode-based Patch Clamp
Automated TEVC On Xenopus Oocytes
By Amplifiers:
8
16
384
768
Others
By End User:
Contract Research Organization
Biopharmaceuticals
Academic & Research Institutes
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Technique
Automated Glass Pipette-based Patch Clamp
Micro-fabricated Planar Electrode-based Patch Clamp
Automated TEVC On Xenopus Oocytes
By Amplifiers:
8
16
384
768
Others
By End User:
Contract Research Organization
Biopharmaceuticals
Academic & Research Institutes
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Technique
Automated Glass Pipette-based Patch Clamp
Micro-fabricated Planar Electrode-based Patch Clamp
Automated TEVC On Xenopus Oocytes
By Amplifiers:
8
16
384
768
Others
By End User:
Contract Research Organization
Biopharmaceuticals
Academic & Research Institutes
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Technique
Automated Glass Pipette-based Patch Clamp
Micro-fabricated Planar Electrode-based Patch Clamp
Automated TEVC On Xenopus Oocytes
By Amplifiers:
8
16
384
768
Others
By End User:
Contract Research Organization
Biopharmaceuticals
Academic & Research Institutes
By Country:
GCC
Israel
Rest of Middle East
Africa
By Technique
Automated Glass Pipette-based Patch Clamp
Micro-fabricated Planar Electrode-based Patch Clamp
Automated TEVC On Xenopus Oocytes
By Amplifiers:
8
16
384
768
Others
By End User:
Contract Research Organization
Biopharmaceuticals
Academic & Research Institutes
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
Sophion Bioscience A/S *
Company Overview
Material Portfolio
Financial Performance
Key Highlights
Market Strategies
Nanion Technologies GmbH
NeoBiosystems, Inc.
Multi Channel Systems MCS GmbH
Fluxion Biosciences
Molecular Devices, LLC
Scitech Korea Inc.
HEKA Elektronik GmbH
“*” marked represents similar segmentation in other categories in the respective section.